Carey named Division Chief of Hematology-Oncology and Physician-in-Chief of the N.C. Cancer Hospital

Lisa A. Carey, MD, has been appointed Chief of the Division of Hematology and Oncology at the University of North Carolina School of Medicine and Physician-in-Chief of the N.C. Cancer Hospital.

Dr. Carey, a member of the UNC faculty for more than ten years, is Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, Professor of Medicine, Medical Director of the UNC Breast Center, and Associate Director for Clinical Research at UNC Lineberger Comprehensive Cancer Center.

In her role as division chief, Dr. Carey will be responsible for the overall administration of the division, including clinical practice, educational activities, research programs, fiscal management, and meeting the missions of patient care, research, and education. This includes leading a diverse group of more than 50 clinicians, investigators, physician extenders and fellows, which has grown substantially.

As Physician-in-Chief, Dr. Carey is responsible for the clinical operations of the N.C. Cancer Hospital and will work with Shelley Earp, MD, Director of UNC Lineberger and UNC Cancer Care to coordinate care of cancer patients throughout the UNC Health Care System.  More than 135,000 patients with cancer are served each year by UNC Health Care through inpatient and outpatient clinics.

As Physician-in-Chief, Dr. Carey will report to Dr.  Earp, in his role as Director of UNC Cancer Care, Brian Goldstein, MD, MBA, Chief Operations Officer of UNC Hospitals and Marlene Rifkin, Senior Vice President of UNC Hospitals who oversees Oncology Services. In her role as Division Chief she will report to Dr. Runge, Chair of the Department of Medicine.“Dr. Carey is recognized internationally as one of the world’s most thoughtful clinician investigators.  Her mastery of cancer biology and genetics and their application to improving patients’ lives sets her apart.  This type of interdisciplinary leadership, combined with her consummate clinical skills, will provide remarkable direction as the division prepares for the new era of cancer care,” said Dr. Earp.